Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity

Acta Diabetologica

Volumn 42, Issue 2, 2005, Pages 104-109

  Hasegawa, G ^a   Ohta, M ^b   Ichida, Y ^a   Obayashi, H ^c   Shigeta, M ^d   Yamasaki, M ^a   Fukui, M ^a   Yoshikawa, T ^a   Nakamura, N ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^c Institute of Bio Response Informatics   (Japan)

^d KYOTO FIRST RED CROSS HOSPITAL   (Japan)

Author keywords

Human; Insulin resistance; Resistin; Type 2 diabetes

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; RESISTIN;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC OBESITY; DISEASE MARKER; FEMALE; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS;

ADIPONECTIN; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; BODY WEIGHT; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; FEMALE; HORMONES, ECTOPIC; HUMANS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MALE; MIDDLE AGED; OBESITY; PATIENT SELECTION; REFERENCE VALUES; RESISTIN;

EID: 21144438388     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00592-005-0187-x     Document Type: Article

References (23)

1. Steppan CM, Bailey ST, Bhat S et al (2001) The hormone resistin links obesity to diabetes. Nature 409:307-312
2. Kim KH, Lee K, Moon YS, Sul HS (2001) A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 276:11252-11256
3. Holcomb IN, Kabakoff RC, Chan B et al (2000) FIZZ, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19:4046-4055
4. Rajala MW, Obici S, Scherer PE, Rossetti L (2003) Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production. J Clin Invest 111:225-230
5. Banerjee RR, Rangwala SM, Shapiro JS et al (2004) Regulation of fasted blood glucose by resistin. Science 303:1195-1198
6. Savage DB, Sewter CP, Klenk ES (2001) Resistin/FIZZ3 expression in relation to obesity and peroxisome proliferators-activated receptor-β action in humans. Diabetes 50:2199-2202
7. Nagaev I, Smith U (2001) Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 285:561-564
8. Engeli JJ, Gorzelniak K, Luft FC, Sharma AM (2002) Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res 10:1-5
9. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BLG, Murphy LJ (2003) Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 149:331-335
10. Zhang JL, Qin YW, Zheng X, Qiu JL, Zou DJ (2003) Serum resistin level in essential hypertension patients with different glucose tolerance. Diabet Med 20:828-831
11. Azuma K, Katsukawa F, Oguchi S et al (2003) Correlation between serum resistin level and adiposity in obese individuals. Obes Res 11:997-1001
12. Lee JH, Chan JL, Yiannakouris N et al (2003) Circulating resistin levels are not associated with obesity or insulin resistance in human and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin resistant, and diabetic subject. J Clin Endocrinol Metab 88:4848-4856
13. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE et al (2003) Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 88:5452-5455
14. McTernan PG, Fisher FM, Valsamakis G et al (2003) Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J Clin Endocrinol Metab 88:6098-6106
15. Youn BS, Yu KY, Park HJ et al (2003) Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab 89:150-156
16. Fujinami A, Obayashi H, Ohta K et al (2004) Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta 339:57-63
17. Hotta K, Funahashi T, Arita Y et al (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vac Biol 20:1595-1599
18. Rosen FS, Mackay I (2001) Resistin, obesity, and insulin resistance - the emerging role of the adipocyte as and endocrine organ. N Engl J Med 18:1345-1346
19. Fasshauer M, Paschke R (2003) Regulation of adipocytokines and insulin resistance. Diabetologia 46:1594-1603
20. Steppan CM, Brown EJ, Wright CM et al (2001) A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 98:502-506
21. Kawanami D, Maemura K, Takeda N et al (2004) Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 314:415-419
22. Verma S, Li SH, Wang CH et al (2003) Resistin promotes endothelial cell activation, further evidence of adipokine-endothelial interaction. Circulation 108:736-740
23. Fehmann HC, Heyn J (2002) Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls. Horm Metab Res 34:671-673